IMCD (IMCD) Hisse Özeti
IMCD N.V. Hollanda, Avrupa'nın geri kalanı, Orta Doğu, Afrika, Kuzey Amerika, Güney Amerika ve Asya-Pasifik'te özel kimyasalların ve bileşenlerin dağıtımını, pazarlamasını ve satışını yapmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 2/6 |
| Gelecekteki Büyüme | 1/6 |
| Geçmiş Performans | 2/6 |
| Finansal Sağlık | 3/6 |
| Temettüler | 4/6 |
IMCD Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
IMCD N.V. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | €91.66 |
| 52 Haftanın En Yüksek Seviyesi | €123.95 |
| 52 Haftanın En Düşük Seviyesi | €68.14 |
| Beta | 0.98 |
| 1 Aylık Değişim | -3.01% |
| 3 Aylık Değişim | 8.12% |
| 1 Yıllık Değişim | -25.48% |
| 3 Yıllık Değişim | -35.29% |
| 5 Yıllık Değişim | -31.67% |
| Halka arzdan bu yana değişim | 309.75% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • May 14
IMCD: Margin Execution And Earnings Quality Should Support Future Re Rating
Narrative update on IMCD The updated analyst price target for IMCD moves to €148.67 from €144.05. This change reflects analysts' revised views on growth, profitability and P/E assumptions after recent target changes from major banks across the sector.Anlatı Güncellemesi • Apr 29
IMCD: Margin Execution And Revenue Mix Should Support Future Re Rating
Analyst price targets for IMCD have edged lower, with recent cuts of €5 to €7 from several banks and a reset range between about €103 and €122. Analysts are factoring in a slightly higher discount rate, a lower assumed future P/E multiple and updated expectations for revenue growth and margins.Recent updates
Anlatı Güncellemesi • May 14
IMCD: Margin Execution And Earnings Quality Should Support Future Re Rating
Narrative update on IMCD The updated analyst price target for IMCD moves to €148.67 from €144.05. This change reflects analysts' revised views on growth, profitability and P/E assumptions after recent target changes from major banks across the sector.Anlatı Güncellemesi • Apr 29
IMCD: Margin Execution And Revenue Mix Should Support Future Re Rating
Analyst price targets for IMCD have edged lower, with recent cuts of €5 to €7 from several banks and a reset range between about €103 and €122. Analysts are factoring in a slightly higher discount rate, a lower assumed future P/E multiple and updated expectations for revenue growth and margins.
Anlatı Güncellemesi • Apr 15
IMCD: Dividend Cut And Lowered Expectations Will Pressure Future Returns
IMCD's updated analyst price target has edged lower by a few euros, with recent revisions between about €103 and €122. These reflect analysts' mixed adjustments to growth, margin and P/E assumptions.
Anlatı Güncellemesi • Mar 31
IMCD: Lower Dividend And Reset Expectations Will Set Up Future Upside
The Analyst Price Target for IMCD has shifted lower to €107.68 from €126.46, reflecting analysts' updated views on slightly softer revenue growth, thinner profit margins and a lower future P/E multiple, supported by a series of recent price target cuts and one upward revision across major banks. Analyst Commentary Recent research shows a mix of optimism and caution around IMCD, with several banks trimming price targets and one raising them, which helps explain why the average target has reset closer to current expectations.Anlatı Güncellemesi • Mar 17
IMCD: Sector Caution And Dividend Reset Will Shape Future Expectations
Analysts have trimmed the IMCD price target, with recent revisions clustering around €100 to €122. This reflects updated views on sector conditions and modest adjustments to revenue growth, discount rate and profit margin assumptions.Anlatı Güncellemesi • Mar 03
IMCD: Sector Caution And New Partnership Will Shape Future Expectations
The analyst fair value estimate for IMCD has been adjusted from €82.00 to €75.00. Analysts cite recent price target changes across major banks, along with more cautious assumptions on discount rates, revenue growth, and margins, as the key drivers of the updated view.Anlatı Güncellemesi • Feb 17
IMCD: Distribution Expansion And CFO Transition Will Support Future Re Rating
Analysts have trimmed their price targets for IMCD by about €14, citing slightly higher discount rate assumptions, revised profit margin expectations, and recent cautious sector views. These developments are reflected in lower price targets and a downgrade to Equal Weight.Anlatı Güncellemesi • Feb 03
IMCD: Cautious Sector Outlook And New Partnership Will Shape Expectations
Analysts have reduced their fair value estimate for IMCD from €107.00 to €82.00. This reflects a lower future P/E assumption and a slightly reduced profit margin outlook, in line with recent Street research that has turned more cautious on chemical distribution and related services.Anlatı Güncellemesi • Jan 20
IMCD: Distribution Deal And CFO Transition Will Support Sector Re Rating
Analysts have lowered their price target on IMCD to about €170.50 from roughly €176.73, citing a reset in sector expectations following cautious views on chemical distribution and a shift in preferred names within European business services. Analyst Commentary Recent research has shifted IMCD to a more neutral stance within European business services, with the rating moved to Equal Weight and the price target set at €100 from €139.Analiz Makalesi • Jan 20
Is There An Opportunity With IMCD N.V.'s (AMS:IMCD) 50% Undervaluation?
Key Insights IMCD's estimated fair value is €148 based on 2 Stage Free Cash Flow to Equity Current share price of...Anlatı Güncellemesi • Jan 06
IMCD: Share Pullback Will Set Up Upside Following New Outperform Coverage
Analysts have trimmed their fair value estimate for IMCD from €127.18 to €126.46, reflecting slightly softer assumptions for revenue growth and profit margin, even as some recent research, including new Outperform coverage, points to potential upside after the recent share pullback. Analyst Commentary Bullish Takeaways Bullish analysts view the recent share pullback as creating a more appealing entry point relative to their updated fair value and the new $72.50 price target.Anlatı Güncellemesi • Dec 17
IMCD Will Likely Gain From New Distribution Deal And Leadership Transition
Analysts have trimmed their fair value estimate for IMCD to approximately €177 from about €182, reflecting slightly higher discount rate assumptions, more moderate revenue growth expectations, and a marginally lower future P/E, partially offset by a firmer margin outlook and recent supportive rating actions despite reduced price targets. Analyst Commentary Bullish analysts continue to frame IMCD as a quality compounder within the specialty chemicals distribution space, highlighting the recent share pullback as an opportunity rather than a sign of structural deterioration.Anlatı Güncellemesi • Dec 03
IMCD: Share Pullback Will Offer Opportunity As New Outperform Ratings Emerge
The analyst price target for IMCD has been trimmed modestly from EUR 131.25 to about EUR 127.18, as analysts factor in slightly slower growth and margin assumptions, even as they highlight recent upgrades and new Outperform initiations as support for a still constructive outlook. Analyst Commentary Recent research updates point to a broadly constructive stance on IMCD, with most commentary emphasizing resilient fundamentals and an attractive entry point following the share price pullback, even as some valuation and macro risks are flagged.Analiz Makalesi • Nov 27
Some Shareholders Feeling Restless Over IMCD N.V.'s (AMS:IMCD) P/E Ratio
It's not a stretch to say that IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 17.6x right now seems...Anlatı Güncellemesi • Nov 19
IMCD: Share Pullback Will Offer Opportunity As Revenue Momentum Builds
IMCD's analyst price target has been revised down from €138.04 to €131.25. Analysts cite moderate adjustments in fair value and market outlook, despite recent supportive coverage and an improved revenue growth forecast.Analiz Makalesi • Nov 12
Does IMCD (AMS:IMCD) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Anlatı Güncellemesi • Nov 04
IMCD: Share Price Pullback Will Offer Attractive Entry As Ratings Improve
The analyst fair value estimate for IMCD has been reduced from EUR 142.43 to EUR 138.04. Analysts cite more cautious assumptions on long-term revenue growth and profit margin forecasts following recent price target adjustments in Street research.Analiz Makalesi • Oct 28
At €93.80, Is IMCD N.V. (AMS:IMCD) Worth Looking At Closely?
IMCD N.V. ( AMS:IMCD ), might not be a large cap stock, but it saw significant share price movement during recent...Anlatı Güncellemesi • Oct 21
Analyst Commentary Highlights Mixed Views on IMCD Amid Minor Valuation Adjustments
Analysts have slightly lowered their fair value estimate for IMCD by less than 1 percent to approximately €142.43. This reflects minor adjustments in growth expectations and recent Street research supporting a cautiously positive outlook, despite recent target downgrades.Analiz Makalesi • Oct 12
Returns On Capital At IMCD (AMS:IMCD) Have Hit The Brakes
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...Anlatı Güncellemesi • Oct 03
Digitalization And M&A Will Expand Pharma And Consumer Markets
IMCD's analyst price target has decreased moderately, from €145.43 to €143.00, as analysts factor in slightly lower expected growth and a reduced profit margin outlook in recent industry assessments. Analyst Commentary Analyst opinions on IMCD remain divided as recent price target changes and rating updates reflect a mix of optimism regarding potential growth and caution due to evolving sector dynamics.Anlatı Güncellemesi • Sep 04
Digitalization And M&A Will Expand Pharma And Consumer Markets
Analysts cite attractive valuation, improved capital allocation, and stabilizing end markets as supportive, but near-term earnings uncertainty and ongoing macroeconomic headwinds have kept IMCD’s consensus price target unchanged at €145.43. Analyst Commentary Valuation now seen as attractive, with shares offering growth at a reasonable price.Analiz Makalesi • Sep 01
An Intrinsic Calculation For IMCD N.V. (AMS:IMCD) Suggests It's 44% Undervalued
Key Insights The projected fair value for IMCD is €170 based on 2 Stage Free Cash Flow to Equity IMCD is estimated to...Analiz Makalesi • Aug 04
We Think IMCD (AMS:IMCD) Can Stay On Top Of Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jul 21
There's Reason For Concern Over IMCD N.V.'s (AMS:IMCD) Price
IMCD N.V.'s ( AMS:IMCD ) price-to-earnings (or "P/E") ratio of 23.9x might make it look like a sell right now compared...Analiz Makalesi • Jul 04
Return Trends At IMCD (AMS:IMCD) Aren't Appealing
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Yeni Anlatı • Nov 25
The Company'S Digital Upgrades And M&A Strategy Ignite Growth Potential Amid Challenges
Continued organic growth through commercial excellence and digital upgrades could boost future revenue and earnings.Hissedar Getirileri
| IMCD | NL Trade Distributors | NL Pazar | |
|---|---|---|---|
| 7D | -5.5% | -0.02% | 0.9% |
| 1Y | -25.5% | -1.2% | 23.2% |
Getiri vs. Endüstri: IMCD geçen yıl % -1.2 oranında getiri sağlayan Dutch Trade Distributors sektörünün gerisinde kaldı.
Getiri vs Piyasa: IMCD geçen yıl % 23.2 oranında getiri sağlayan Dutch Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| IMCD volatility | |
|---|---|
| IMCD Average Weekly Movement | 5.7% |
| Trade Distributors Industry Average Movement | 5.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in NL Market | 7.6% |
| 10% least volatile stocks in NL Market | 2.8% |
İstikrarlı Hisse Senedi Fiyatı: IMCD son 3 ayda Dutch piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: IMCD 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1995 | 5,246 | Marcus Jordan | www.imcdgroup.com |
IMCD N.V. Hollanda, Avrupa'nın geri kalanı, Orta Doğu, Afrika, Kuzey Amerika, Güney Amerika ve Asya-Pasifik'te özel kimyasalların ve bileşenlerin dağıtımını, pazarlamasını ve satışını yapmaktadır. Şirket yapıştırıcılar, çekirdek malzemeler, dolgu takviyeleri, alev geciktiriciler, masterbatch, modifiye ediciler, işletme malzemeleri, pigmentler, plastikleştiriciler, işleme yardımcıları, PUR hammaddeleri, kauçuk elastomerler, çözücüler, stabilizatörler, termoplastik elastomerler, termoplastikler ve diğer katkı maddeleri sağlamaktadır. Aktifler, UV güneş koruyucuları, reoloji değiştiriciler, kıvam arttırıcılar, yüzey aktif maddeler, emülgatörler, yumuşatıcılar, film oluşturucular, nemlendiriciler, mumlar, saç kremleri, saç şekillendirici polimerler, çözücüler, çözünürleştiriciler, pigmentler, inciler, tozlar ve renklendiriciler, opaklaştırıcılar, sedefleştiriciler, koruyucular, antioksidanlar, kokular ve uçucu yağlar sunmaktadır.
IMCD N.V. Temel Bilgiler Özeti
| IMCD temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | €5.41b |
| Kazançlar(TTM) | €217.58m |
| Gelir(TTM) | €4.81b |
24.9x
F/K Oranı1.1x
P/S OranıIMCD aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| IMCD gelir tablosu (TTM) | |
|---|---|
| Gelir | €4.81b |
| Gelir Maliyeti | €3.59b |
| Brüt Kâr | €1.22b |
| Diğer Giderler | €1.00b |
| Kazançlar | €217.58m |
Son Raporlanan Kazançlar
Dec 31, 2025
Sonraki Kazanç Tarihi
Jul 29, 2026
| Hisse başına kazanç (EPS) | 3.69 |
| Brüt Marj | 25.38% |
| Net Kâr Marjı | 4.53% |
| Borç/Özkaynak Oranı | 82.6% |
IMCD uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
2.0%
Mevcut Temettü Verimi49%
Ödeme OranıŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/05/20 01:19 |
| Gün Sonu Hisse Fiyatı | 2026/05/20 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
IMCD N.V. 23 Bu analistlerden 12, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Gaurav Jain | Barclays |
| James Stewart | Barclays |
| Anil Shenoy | Barclays |